Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Journal of Nutrition Education and Behavior
|
June 6, 2002
Nutrition jeopardy
Melanie Tracy Burns, Michelle Benoit, Denise Bulvan
Gynecologic Oncology
|
November 5, 2023
Survival differences by race and surgical approach in early-stage operable cervical Cancer
Rebekah Summey, Michelle Benoit, M Yvette Williams-Brown
International Immunopharmacology
|
April 9, 2013
Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates
Michael J McCluskie, David C Pryde, David P Gervais, et al.
International Immunopharmacology
|
September 26, 2015
Anti-nicotine vaccines: Comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates
Michael J McCluskie, Jennifer Thorn, David P Gervais, et al.
Immunopharmacology and Immunotoxicology
|
April 29, 2016
The effect of preexisting anti-carrier immunity on subsequent responses to CRM197 or Qb-VLP conjugate vaccines
Michael J McCluskie, Dana M Evans, Ningli Zhang, et al.
Plos One
|
October 8, 2013
Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice
David C Pryde, Lyn H Jones, David P Gervais, et al.
Pediatric Pulmonology
|
May 15, 2003
Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry
Curt Parnes, Judith Guillermin, Rolf Habersang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Journal of Nutrition Education and Behavior
|
June 6, 2002
Nutrition jeopardy
Melanie Tracy Burns, Michelle Benoit, Denise Bulvan
Gynecologic Oncology
|
November 5, 2023
Survival differences by race and surgical approach in early-stage operable cervical Cancer
Rebekah Summey, Michelle Benoit, M Yvette Williams-Brown
International Immunopharmacology
|
April 9, 2013
Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates
Michael J McCluskie, David C Pryde, David P Gervais, et al.
International Immunopharmacology
|
September 26, 2015
Anti-nicotine vaccines: Comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates
Michael J McCluskie, Jennifer Thorn, David P Gervais, et al.
Immunopharmacology and Immunotoxicology
|
April 29, 2016
The effect of preexisting anti-carrier immunity on subsequent responses to CRM197 or Qb-VLP conjugate vaccines
Michael J McCluskie, Dana M Evans, Ningli Zhang, et al.
Plos One
|
October 8, 2013
Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice
David C Pryde, Lyn H Jones, David P Gervais, et al.
Pediatric Pulmonology
|
May 15, 2003
Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry
Curt Parnes, Judith Guillermin, Rolf Habersang, et al.
Page
of 1